Clinical trials
Carcinoma, Non-Small-Cell Lung trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
624 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 7 |
| 2002 | 5 |
| 2003 | 9 |
| 2004 | 11 |
| 2005 | 20 |
| 2006 | 28 |
| 2007 | 16 |
| 2008 | 18 |
| 2009 | 21 |
| 2010 | 17 |
| 2011 | 15 |
| 2012 | 14 |
| 2013 | 13 |
| 2014 | 25 |
| 2015 | 31 |
| 2016 | 23 |
| 2017 | 36 |
| 2018 | 34 |
| 2019 | 33 |
| 2020 | 26 |
| 2021 | 35 |
| 2022 | 42 |
| 2023 | 31 |
| 2024 | 34 |
| 2025 | 33 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 287 |
| Active, not recruiting | 117 |
| Terminated | 94 |
| Recruiting | 89 |
| Unknown status | 17 |
| Withdrawn | 10 |
| Not yet recruiting | 8 |
| Available | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 46 |
| Novartis Pharmaceuticals | 36 |
| Bristol-Myers Squibb | 35 |
| Pfizer | 31 |
| University Health Network, Toronto | 27 |
| Eli Lilly and Company | 24 |
| Merck Sharp & Dohme LLC | 23 |
| Hoffmann-La Roche | 19 |
| GlaxoSmithKline | 16 |
| Alliance for Clinical Trials in Oncology | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 624 |
| Lung Neoplasms | 162 |
| Neoplasms | 68 |
| Colorectal Neoplasms | 49 |
| Melanoma | 45 |
| Breast Neoplasms | 37 |
| Neoplasm Metastasis | 35 |
| Squamous Cell Carcinoma of Head and Neck | 33 |
| Carcinoma | 26 |
| Ovarian Neoplasms | 26 |
Trials
Showing 76 to 100 of 624. Each trial links to its page on Pharma Observatory.
524 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.